Compare Elevance Health Inc. Common Stock (ELV) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Elevance Health Inc. Common Stock trades at $429.07 (market cap $92.23B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Elevance Health Inc. Common Stock is far larger — about 62.3× uniQure N.V. Ordinary Shares's market cap, and Elevance Health Inc. Common Stock pays a 1.62% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elevance Health Inc. Common Stock for 1 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| ELV | QURE | |
|---|---|---|
Market Cap | $92.23B | $1.48B |
Volume | 1,842,737 | 2,488,780 |
Sector | Health | Health |
52-Week High | $428.09 | $70.59 |
52-Week Low | $280.74 | $9.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $113.04B | $728.62M |
Dividend Yield | 1.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Elevance Health (ELV) trades at $425.27, up 0.75% with a bullish technical outlook and strong institutional support. The stock shows consistent earnings beats with Q1 2026 EPS of $12.58 beating expectations by 16%, while maintaining solid fundamentals with $199.13B revenue and 11.2% ROE. Recent Medicare Advantage plan announcements and positive analyst coverage reinforce growth prospects.
ELV presents a compelling investment case with 71% analyst buy ratings and $445.13 price target offering 4.7% upside. However, declining 2026 profit margins to 2.46% and regulatory uncertainty in healthcare sector pose risks. The stock's current valuation at 18.81 P/E appears reasonable given earnings momentum and market position.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
